STOCK TITAN

Ecovyst Inc 10-Q Filings

ECVT NYSE

Every 10-Q that Ecovyst Inc (ECVT) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow ECVT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ECVT filings page.

Rhea-AI Summary

Ecovyst Inc. posted Q2 2026 sales of approximately $249.962M, up from $176.065M a year earlier. Gross profit was $49.847M and operating income $19.361M. Net income from continuing operations reached $10.697M, while a $3.75M post‑closing purchase price adjustment on the 2025 Advanced Materials & Catalysts sale drove a $2.832M loss from discontinued operations, yielding total net income of $7.865M, or $0.07 per diluted share.

For the first half of 2026, net income was $12.179M versus $2.389M in 2025, with $51.287M of operating cash flow. On June 30 Ecovyst closed the $190M Calabrian sulfur dioxide and derivatives acquisition, paying $183.286M in cash and recording $71.524M of goodwill, funded in part by a $100M increase in its term loan. As of June 30, cash and cash equivalents were $87.763M and long‑term debt, net, was $492.952M. The company repurchased 3.226M shares for $35.721M under its stock repurchase program, with $146.486M remaining authorized.

Rhea-AI Summary

Ecovyst Inc. reported a strong turnaround for the three months ended March 31, 2026, with continuing-operations sales rising to $215.0 million from $143.1 million and net income from continuing operations improving to $5.7 million from a loss of $8.1 million a year earlier.

Gross profit nearly doubled to $36.4 million as higher volumes of virgin and regenerated sulfuric acid, better contract pricing and pass-through of higher sulfur costs more than offset increased manufacturing expenses. Adjusted EBITDA from continuing operations increased to $39.8 million, helped by the Waggaman, Louisiana asset acquisition and strong refining and industrial demand.

The company repurchased 3.2 million shares for about $35.7 million, ending the quarter with $162.6 million in cash and no ABL borrowings against a $397.1 million term loan. Ecovyst also disclosed a signed agreement to acquire INEOS’s Calabrian sulfur derivatives business for $190 million, aiming to expand its sulfur-based product portfolio.

Rhea-AI Summary

Ecovyst Inc. reported Q3 2025 results with sales of $204,907 and operating income of $28,275. Net income from continuing operations was $372 as a higher tax provision weighed on results.

The company entered a definitive agreement to sell its Advanced Materials & Catalysts business to Technip Energies for $556,000, subject to regulatory approvals and customary closing conditions. In connection with held-for-sale accounting, Ecovyst recorded an $83,898 impairment in Q3, driving a discontinued operations loss of $79,627 and a total net loss of $79,255.

Year to date, sales were $524,082 with a net loss of $76,866. Cash from operating activities was $98,547; capital expenditures were $51,596, and the Cornerstone sulfuric acid asset acquisition closed for $41,315. The company repurchased 3,536,364 shares for $27,387 under its ongoing authorization. Cash was $81,976 and term loan debt was $864,271; the term loan rate was 5.98% at September 30, 2025. Shares outstanding were 114,019,414 as of October 29, 2025.